HNC042

N/A

Report date: 2025/11/14 20:00:34
NME

Base Information

Drug NameHNC042
Drug Alias NameHNC-042
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Henovcom Bioscience Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesHeilongjiang Zbd Pharmaceutical Co LtdGuangzhou Henovcom Bioscience Co Ltd
Active IndicationsN/A
Inactive IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection

Other Information

ATC CodeN/A
Related LinksN/A